Research
Print page Print page
Switch language
The Capital Region of Denmark - a part of Copenhagen University Hospital
Published

Editorial Commentary: When should the patient with an inherited cardiac disease have an ICD?

Research output: Contribution to journalEditorialResearchpeer-review

  1. Editorial commentary: Subclinical thyroid dysfunction and cardiovascular risk: Nothing to lose, everything to gain?

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Change in body mass index from childhood onwards and risk of adult cardiovascular disease

    Research output: Contribution to journalReviewResearchpeer-review

  3. An overview of current and emerging devices for percutaneous left atrial appendage closure

    Research output: Contribution to journalReviewResearchpeer-review

  4. Current use of beta-blockers in patients with coronary artery disease

    Research output: Contribution to journalReviewResearchpeer-review

  1. Diabetes and the Risk of Sudden Cardiac Death

    Research output: Contribution to journalReviewResearchpeer-review

  2. Defibrillators for prevention from sudden cardiac death: is it that easy?-Authors' reply

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Transethnic Genome-Wide Association Study Provides Insights in the Genetic Architecture and Heritability of Long QT Syndrome

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. Sudden cardiac death among persons with diabetes aged 1-49 years: a 10-year nationwide study of 14 294 deaths in Denmark

    Research output: Contribution to journalJournal articleResearchpeer-review

View graph of relations

The implantable cardioverter defibrillator (ICD) is often considered a routine intervention for an inherited heart rhythm disorder (IHRD) despite there being little to no randomized data for non-ischemic indications. Furthermore, existing IHRD studies often do not report adverse ICD outcomes, and observational data increasingly show that complications are under-recognized. Only recently have tools emerged to address the rational use of ICDs for specific forms of IHRD, although the acceptable risk of device complications remains unestablished. Here, we summarize the evidence of ICD benefit and harm in IHRD, highlight current knowledge gaps, and propose alternative and adjunctive options to the transvenous ICD.

Original languageEnglish
JournalTrends in Cardiovascular Medicine
Volume30
Issue number7
Pages (from-to)422-423
Number of pages2
ISSN1050-1738
DOIs
Publication statusPublished - Oct 2020

    Research areas

  • Arrhythmogenic right ventricular cardiomyopathy, Brugada syndrome, Implantable cardioverter defibrillator, Inherited arrhythmia, Long qt syndrome

ID: 59483929